レイモンド・ジェームズはエンコンパス・ヘルス・コー (EHC) の株を7.8%に増やし,Q2のEPSはコンセンサスに0.10ドルで勝った. Raymond James increased stake in Encompass Health Co. (EHC) to 7.8%, and Q2 EPS beat consensus by $0.10.

Raymond James & Associatesと他の機関投資家は第2四半期にEncompass Health Co. (NYSE: EHC) の株価を増加させ,Raymond Jamesが9,701株を購入し,7.8%のポジションを獲得しました. Raymond James & Associates and other institutional investors increased their stakes in Encompass Health Co. (NYSE: EHC) in Q2, with Raymond James buying 9,701 shares, resulting in a 7.8% position. Encompass Healthは第2四半期のEPSを1.1ドルと報告し,コンセンサス推定を0.10ドル上回り,四半期配当を0.17ドルと発表した. Encompass Health reported Q2 EPS of $1.11, beating the consensus estimate by $0.10, and announced a $0.17 quarterly dividend. スティーブンズ,バークレイス,UBSグループなど様々な企業のアナリストは,同社に買い物または強い買い物評価を与えた. Analysts from various firms, including Stephens, Barclays, and UBS Group, have given the company a buy or strong buy rating.